Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in ob/ob mice

被引:20
|
作者
Shimazu-Kuwahara, Satoko [1 ]
Harada, Norio [1 ]
Yamane, Shunsuke [1 ]
Joo, Erina [1 ]
Sankoda, Akiko [1 ]
Kieffer, Timothy J. [2 ]
Inagaki, Nobuya [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan
[2] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada
来源
MOLECULAR METABOLISM | 2017年 / 6卷 / 03期
关键词
GIP; Hyperphagia; Obesity; Insulin resistance; ob/ob; GASTRIC-INHIBITORY POLYPEPTIDE; TYPE-2; DIABETES-MELLITUS; ENTEROENDOCRINE K CELLS; DIET-INDUCED OBESITY; HIGH-FAT DIET; BYPASS-SURGERY; INCRETIN LEVELS; LEPTIN; STIMULATION; INTOLERANCE;
D O I
10.1016/j.molmet.2017.01.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Glucose-dependent insulinotropic polypeptide (GIP) is released during meals and promotes nutrient uptake and storage. GIP receptor knockout mice are protected from diet induced weight gain and thus GIP antagonists have been proposed as a treatment for obesity. In this study, we assessed the role of GIP in hyperphagia induced obesity and metabolic abnormalities in leptin deficient (Lep(ob/ob)) mice. Methods: We crossbred GIP-GFP knock-in homozygous mice (GIPgfp/gfp) that have complete GIP knockout, and mice heterozygous for the ob mutation ( Lep(ob/+))mice to generate Lep(ob)/(+)/GIP(+/ +), Lep(ob/ob)/GIP(+/+), and Lep(ob/ob)/GIP(gfp/gfp) mice. Male animals were weighed weekly and both oral glucose and insulin tolerance testing were performed to assess glucose homeostasis and circulating profiles of GIP and insulin. Body composition was evaluated by computerized tomography ( CT) scan and analyses of indirect calorimetry and locomotor activity were performed. Results: Postprandial GIP levels were markedly elevated in Lep(ob/ob)/GIP(+/+) mice compared to Lep(ob/ob)/GIP(+/+) controls and were undetectable in Lep(ob/ob)/GIP(gfp/gfp) mice. Insulin levels were equivalently elevated in both Lep(ob/ob)/GIP(+/+) and Lep(ob/ob)/GIP(gfp/gfp) mice compared to controls at 8 weeks of age but the hyperinsulinemia was marginally reduced in Lep(ob/ob)/GIP(gfp/gfp) by 21 weeks, in association with amelioration of glucose intolerance. Both Lep(ob/ob)/GIP(+/+) and Lep(ob/ob)/GIP(gfp/gfp) mice remained equivalently insulin resistant. Body weight gain and subcutaneous and visceral fat volume of both Lep(ob/ob)/GIP(+/+) and Lep(ob/ob)/GIP(gfp/gfp) mice were significantly higher than that of Lep(ob/+)/GIP(+/+) mice, while no significant differences were seen between Lep(ob/ob)/GIP(+/+) and Lep(ob/ob)/GIP(gfp/gfp) mice. Locomotor activity and energy expenditure were decreased in both Lep(ob/ob)/GIP(+/+) and Lep(ob/ob)/GIP(gfp/gfp) mice compared to control Lep(ob/+)/ GIP(+/+) mice, while no significant differences were seen between Lep(ob/ob)/GIP(+/+) and Lep(ob/ob)/GIP(gfp/gfp) mice. There was no significant difference in fat oxidation among the three groups. Fat content in liver was significantly lower in Lep(ob/ob)/GIP(gfp/gfp) compared to Lep(ob/ob)/GIP(+/+) mice, while that of control Lep(ob/+)/GIP(+/ +) mice was the lowest. Conclusions: Our results indicate that GIP knockout does not prevent excess weight gain and metabolic derangement in hyperphagic leptin deficient mice. (C) 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license
引用
收藏
页码:288 / 294
页数:7
相关论文
共 50 条
  • [1] Deficiency of glucose-dependent insulinotropic polypeptide (GIP) secretion alleviates increasing obesity and insulin resistance with aging
    Kanemaru, Y.
    Harada, N.
    Kuwahara, S. S.
    Yamane, S.
    Ikeguchi, E.
    Murata, Y.
    Kyo, S.
    Inagaki, N.
    [J]. DIABETOLOGIA, 2019, 62 : S250 - S250
  • [2] Monoclonal Antibodies (mAbs) to Glucose-Dependent Insulinotropic Polypeptide (GIP) Prevent and Treat Obesity in Wild-Type (wt) and Leptin-Deficient (ob/ob) Mice
    Wolfe, Michael
    Griffin, Patrick H.
    Appajosyula, Sireesh
    Boylan, Michael O.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1038 - S1038
  • [3] THE PREVENTION AND TREATMENT OF OBESITY IN WILD-TYPE (WT) AND HYPERPHAGIC LEPTIN-DEFICIENT (OB/OB) MICE USING MONOCLONAL ANTIBODIES (MABS) TO GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP) OCCURS INDEPENDENTLY OF APPETITE SUPPRESSION
    Wolfe, M. M.
    Griffin, Patrick
    Appajosyula, Sireesh
    Boylan, Michael O.
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S937 - S937
  • [4] Increased glucose-dependent insulinotropic polypeptide (GIP) secretion in acromegaly
    Peracchi, M
    Porretti, S
    Gebbia, C
    Pagliari, C
    Bucciarelli, P
    Epaminonda, P
    Manenti, S
    Arosio, M
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 145 (01) : R1 - R4
  • [5] Effects of glucose-dependent insulinotropic polypeptide (GIP) on acid secretion in the rat
    Wolfe, MM
    Zhao, KB
    Jarboe, LA
    Tseng, CC
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A356 - A356
  • [6] FEEDBACK-REGULATION OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP) SECRETION BY INSULIN IN CONSCIOUS RATS
    BRYERASH, M
    CHEUNG, A
    PEDERSON, RA
    [J]. REGULATORY PEPTIDES, 1994, 51 (02) : 101 - 109
  • [7] GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GASTRIC INHIBITORY POLYPEPTIDE; GIP)
    McIntosh, Christopher H. S.
    Widenmaier, Scott
    Kim, Su-Jin
    [J]. VITAMINS AND HORMONES INSULIN AND IGFS, 2009, 80 : 409 - 471
  • [8] N-terminally truncated metabolite of glucose-dependent insulinotropic polypeptide (GIP) but not glucagon-like peptide-1 (GLP-1) improves glucose homeostasis in ob/ob mice through alleviation of insulin resistance
    Irwin, N.
    Parker, J. C.
    Gault, V. A.
    Greer, B.
    Harriott, P.
    O'Harte, F. P. M.
    Flatt, P. R.
    [J]. DIABETIC MEDICINE, 2007, 24 : 22 - 22
  • [9] Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice
    Irwin, N.
    McClean, P. L.
    O'Harte, F. P. M.
    Gault, V. A.
    Harriott, P.
    Flatt, P. R.
    [J]. DIABETOLOGIA, 2007, 50 (07) : 1532 - 1540
  • [10] Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice
    N. Irwin
    P. L. McClean
    F. P. M. O’Harte
    V. A. Gault
    P. Harriott
    P. R. Flatt
    [J]. Diabetologia, 2007, 50 : 1532 - 1540